E-Commerce China DangDang (DANG)
E-Commerce China DangDang R&D Expense: -6.52M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
DANG R&D Expense Rankings
| Overall | 99th percentile | 3 of 1764 |
| Sector | 99th percentile | 1 of 197 in Services |
| Industry | 85th percentile | 1 of 7 in Catalog & Mail Order Houses |
DANG R&D Expense Range, Past 5 Years
| Minimum | -6.52M | Dec 2011 |
| Maximum | 3.31M | Sep 2011 |
| Average | 0.00 |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these DANG related companies
DANG News
@Michal_Mac Reverse Stock Split proposal in $THQI: http://stks.co/3zjd --^ $dang & my order just filled. oh well whatever it takes.
about 3 days ago by Good2go
about 3 days ago by Good2go
$DANG I hope this goes to 1 or 2 dollars so I can buy in a position!
about 4 days ago by BiopharmaPro
about 4 days ago by BiopharmaPro
@reddyteddy99 $RENN $DANG have lost 30% in a month. gimme a break no stock haz lost this much! i called this hype long ago and u know it
about 4 days ago by johnkelly
about 4 days ago by johnkelly
$RENN $DANG lost all traction/hype after $FB hype faded az i've been calling all along
about 4 days ago by johnkelly
about 4 days ago by johnkelly
$RENN $DANG sub-5 stocks. been preaching this all along. abowt time justice served
about 5 days ago by johnkelly
about 5 days ago by johnkelly
My new rule is to never trade the likes of $dang $renn and $scei ever again.
about 6 days ago by Alfungus
about 6 days ago by Alfungus
$DANG Great buy at this level.... All long and betting a lot on DANG. This boy is ready to pop
about 7 days ago by rtoretzky
about 7 days ago by rtoretzky
Unusual 11 Mid-Day Movers 05/17: (MEG) (GALE) (XG) Higher; (WFR) (SVNT) (DANG) Lower
May 17, 1:06PM Street Insider
May 17, 1:06PM Street Insider
Morning Movers 05/17: (MEG) (GALE) (VELT) Higher; (WFR) (AAP) (DANG) (VNET) Lower
May 17, 11:20AM Street Insider
May 17, 11:20AM Street Insider
China Dangdang (DANG) Posts Narrower than Expected Q1 Loss of 20c/Share; Guides Q2 Revs
May 17, 7:02AM Street Insider
May 17, 7:02AM Street Insider
Transaction volume up 73% during Q1 at B2C sites, Shanghai Daily reports
May 10, 9:35AM theflyonthewall.com
May 10, 9:35AM theflyonthewall.com
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| DANG | 5.38 | -0.17 | -3.06% | 427.17M |
| DAN | 13.39 | -0.17 | -1.25% | 1.975B |
| DAL | 11.37 | +0.10 | +0.89% | 9.614B |
| DAKT | 7.15 | -0.03 | -0.42% | 299.23M |
| CY | 13.25 | +0.11 | +0.84% | 2.052B |
| CXZ | 0.35 | -0.01 | -2.78% | 18.86M |
| CXW | 26.08 | -0.18 | -0.69% | 2.596B |
| CXS | 10.02 | -0.06 | -0.60% | 767.73M |
| CXPO | 4.12 | -0.08 | -1.90% | 185.94M |
| CXO | 89.67 | +0.82 | +0.92% | 9.300B |
